Valuation: Ovation Science Inc.

Market Cap 768K 545K 478K 446K 410K 52.09M 781K 5.29M 2.07M 25.83M 2.05M 2M 89.25M P/E 2024
-2.68x
P/E 2025 -2.26x
Enterprise Value 979K 695K 610K 568K 522K 66.38M 996K 6.74M 2.64M 32.92M 2.61M 2.55M 114M EV / Sales 2024
13.2x
EV / Sales 2025 25.7x
Free-Float
76.54%
Yield 2024 *
-
Yield 2025 -
1 day+50.00%
Current month+100.00%
1 month+50.00%
3 months+20.00%
Current year-25.00%
1 month 0.02
Extreme 0.02
0.03
Current year 0.02
Extreme 0.015
0.04
1 year 0.02
Extreme 0.015
0.05
3 years 0.01
Extreme 0.01
0.08
5 years 0.01
Extreme 0.01
0.14
10 years 0
Extreme 0
0.65
Manager TitleAgeSince
Director of Finance/CFO 63 30/10/2023
Chief Executive Officer 77 04/10/2017
Director TitleAgeSince
Director/Board Member 77 04/10/2017
Director/Board Member 63 04/10/2017
Director/Board Member 86 02/02/2018
Date Insider Type Main position Quantity % Market Cap.
7/4/25 Buy

Director

100,000 0.2642%
31/1/25 Buy

Director

100,000 0.2642%
31/1/25 Other

Director

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
+50.00%0.00%-40.00%+50.00% 544K
+1.96%+1.10%+2.49%-9.02% 228B
+1.93%+1.11%+32.35% - 49.76B
-5.92%-9.38%+94.23% - 9.04B
-0.73%+6.31%+36.48%-47.59% 8B
-3.81%+1.28%-11.28%+6.74% 5.21B
-0.84%+4.81%-30.76%-27.77% 4.95B
+1.28%+3.13%+1.26%-15.74% 3.99B
+2.59%+4.80%-28.44%-46.01% 3.4B
+0.18%+0.18%-46.50%-77.00% 2.39B
Average +4.63%+1.06%+0.98%-20.80% 31.48B
Weighted average by Cap. +1.46%-0.72%+9.23%-11.50%

Financials

2024 2025
Net sales 113K 80.35K 70.51K 65.66K 60.4K 7.68M 115K 779K 305K 3.81M 302K 295K 13.15M 67.89K 48.18K 42.28K 39.37K 36.21K 4.6M 69.05K 467K 183K 2.28M 181K 177K 7.89M
Net income -456K -324K -284K -265K -243K -30.93M -464K -3.14M -1.23M -15.34M -1.22M -1.19M -53M -631K -448K -393K -366K -337K -42.8M -642K -4.34M -1.7M -21.23M -1.68M -1.65M -73.34M
Net Debt 265K 188K 165K 154K 141K 17.98M 270K 1.82M 714K 8.92M 706K 691K 30.81M 211K 150K 131K 122K 112K 14.29M 214K 1.45M 568K 7.09M 562K 549K 24.49M
Logo Ovation Science Inc.
Ovation Science Inc. is a Canada-based drug development company. The Company develops topical and transdermal cannabidiol (CBD)/ tetrahydrocannabinol (THC) and other cannabinoid products which are out-licensed and also distributed under its own brands; ARLO CBD Beauty and InVibe MD (wellness line); all powered by its patented Invisicare skin delivery technology. The Company manufactures, distributes, sells, markets, sub-licenses and promotes products formulated with Invisicare, containing cannabinoids, hemp seed oil or synthetic derivatives of cannabis. The Company has developed topical and transdermal creams and lotions made with CBD, THC and combinations thereof plus hemp seed oil. Invisicare is a patented polymer-based technology for topical and transdermal skincare products. ARLO CBD Beauty offers science-based skincare solutions. Invibe MD offers a health and wellness product line infused with hemp-derived CBD and developed using Invisicare drug delivery technology.
Employees
-
Date Price Change Volume
28/07/26 CAD 0.0300 +50.00% 20,000
23/07/26 CAD 0.000000 - 100
  1. Stock Market
  2. Stocks
  3. OVAT Stock